Educare Webinars

 

 

 

In this webinar, the heads of different cardiology societies within LATAM will discuss COVID-19 status in each country and the strategies to communicate to patients the importance of cardiovascular disease and ensuring safety conditions during interventions. You will learn facts such as:

  • 76% of the specialists participating on the Webinar are conducting teleconsultation
  • More than the 50% of the participants are using WhatsApp as a tool of Teleconsultation, Zoom ranking as the second used tool
  • About 60% of participants, are actively communicating to the patients the risk of late consultation in cardiovascular disease
  • Cases of patients with dyspnea going to the ER assuming they had COVID-19 but they were suffering a heart attack
  • Regulations of Telemedicine
  • A major factor of why patients with cardiovascular disease are not going to consultation is because they are afraid of getting infected with COVID-19

 

 

Dr. Juan Granada


Dr. Juan Granada (USA) 
Moderator, President and CEO of
The Cardiovascular Research Foundation (CRF)

Dr. Ana Salvati Dr. Ana Salvati (Argentina)
Former President of the Argentinian
Society of Cardiology 
   
Dr. Marcelo Quiroga Dr. Marcelo Queiroga (Brasil)
President of the Brazilian
Society of Cardiology
Marco Alcocer Dr. Marco Alcocer (Mexico) 
President of the Mexican
Society of Cardiology
Dr. Cesar Hernandez Dr. Cesar Hernandez (Colombia)
President of the Colombian
Society of Cardiology

 

 

 

  • Current Status of COVID-19 impact in each country within LATAM
  • COVID-19: Number of deceased, infection and drop in number of cardiology procedures
  • Security Protocols for patients and Staff in no interventional environments
  • Cases of patients with dyspnea going to the ER assuming they had COVID-19 but they were suffering a heart attack.
  • Screening of patients before intervention (Covid Test, PPEs)
  • Telemedicine
  • Communication Strategy for patients

 

 

 

 


 

This program was supported by: 

Be Calculated: Optimizing Stent Performance in Calcific Coronary Artery Disease